Global Spine Biologics Market, By Product (Bone Allografts, Bone Graft Substitute, Platelet Rich Plasma, Bone Marrow Aspirate Therapy), Surgery Type (Anterior Cervical Discectomy and Fusion (ACDF), Transforamenal Lumbar Interbody Fusion (TLIF), Anterior Lumbar Interbody Fusion (ALIF), Lateral Lumbar Interbody Fusion (LLIF)), End-User (Hospitals, Spinal Surgery Centers, Orthopedic Clinics, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Spine Biologics Market
The spine biologics market is expected to witness market growth at a rate of 4.03% in the forecast period of 2021 to 2028. Data Bridge Market Research report on spine biologics market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The increase in the prevalence of spine disorders globally is escalating the growth of spine biologics market.
A biologic material refers to a substance which assists in altering the surrounding environment and has an effect on the environment that progresses through an active biological process. These effects can be seen through increased cellular activity, differentiation and growth. Spine biologics comprises of material which is extensively used in the bone fusion surgery, degenerative disc disease and spinal cord injury.
The rise in the cases of degenerative spine disorders and significant increase in treatment rates across the globe act as the major factors driving the growth of spine biologics market. The technological advancements in bone grafting procedures, important role of these biologics in the spine surgery and high demand for minimally invasive procedures accelerate the spine biologics market growth. The high usage of the biomaterials in the treatment of degenerative disc diseases, spinal cord injuries and bone fusion surgeries and high adoption owning to its quick healing, minimum postoperative time and the capability to activate cellular expansion further influence the spine biologics market. Additionally, the growing geriatric population, increasing awareness regarding the newly developed spine treatment techniques, research and development activities and surge in healthcare expenditure positively affect the spine biologics market. Furthermore, development of technologically advanced and cost-effective products extends profitable opportunities to the spine biologics market players in the forecast period of 2021 to 2028.
On the other hand, high cost associated with the procedure and unfavorable reimbursement scenario is the factors expected to obstruct the spine biologics market growth. The lack of understanding among patients and dearth of expertise and professional knowledge are projected to challenge the spine biologics market in the forecast period of 2021 to 2028.
This spine biologics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on spine biologics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Spine Biologics Market Scope and Market Size
The spine biologics market is segmented on the basis of product, surgery type and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product, the spine biologics market is segmented into bone allografts, bone graft substitute, platelet rich plasma and bone marrow aspirate therapy.
- On the basis of surgery type, the spine biologics market is segmented into anterior cervical discectomy and fusion (ACDF), transforamenal lumbar interbody fusion (TLIF), anterior lumbar interbody fusion (ALIF), lateral lumbar interbody fusion (LLIF) and others.
- On the basis of end-user, the spine biologics market is segmented into hospitals, spinal surgery centers, orthopedic clinics and others.
Global Spine Biologics Market Country Level Analysis
The spine biologics market is analyzed and market size insights and trends are provided by country, product, surgery type and end-user as referenced above.
The countries covered in the spine biologics market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the spine biologics market because of the stable economic growth, rising prevalence of spine disorders such as spinal stenosis, disc-related issues and spondylolisthesis and high adoption of minimally invasive surgeries. Asia-Pacific is estimated to witness the fastest growth in the forecast period of 2021-2028 due to the presence of a large patient pool, improvements in infrastructure and healthcare facilities, high prevalence of spine injuries, surge in healthcare expenditure and growth in awareness among surgeons and patients.
The country section of the spine biologics market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The spine biologics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for spine biologics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the spine biologics market. The data is available for historic period 2011-2019.
Competitive Landscape and Spine Biologics Market Share Analysis
The spine biologics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to spine biologics market.
The major players covered in the spine biologics market report are Arthrex, Inc., Cesca Therapeutics Inc., DePuy Synthes, Orthopaedic Seminar, Exactech, Inc., K2M, Inc., Lattice Biologics Ltd, Medtronic, NuTech Spine, Inc., NuVasive Inc., Orthofix Holdings, Inc., Regen Lab USA LLC, RTI Surgical Holdings, Inc., Stryker, Wright Medical Group N.V., XTANT MEDICAL, Zimmer Biomet, Smith & Nephew, Dr PRP USA LLC among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-